I posted this on the other threadQuone, have you ever had a colonoscopy? "Stool tests for candida are unreliable, as they do not shed regularly and many bowel movements (submitted for stool tests) will not show overgrowth even if there is one."The thing is candida is a visable organism. There are also different kinds of course.The medical establishment doesn't believe in the kind were talking about and it can't be tested for and can been seen under a electronmicroscope? It would seem the only way to have this diagnoses is to self diagnose. Yes?Not sure where you got this information from really. The bowel wall is constantly shedding it cells. How does candida stay there? Or not be seen? How is candida toxic if you can find it in the blood or on stool testing. They do a lot of research on bacteeria and the colon, including conditions like IBD and all kninds of conditions as well as IBS. Yet they don'ty recogonized the kind of candida your talking about. A friend of mine worked doing colonoscopies did not beliege in that condition. And others are using electron microscopes. Yet no overgrowth? What keeps them in check from a major overgrowth?Also the gut brain runs a program on pathogens in the gut, it developed to expell pathogens from the body as quickly as possible causes, d, so it would seem even more unlikely to cause c, that would not be benefical to the organism.There also from above"Candida is a normal part of the bowel flora (the organisms that naturally live inside our intestines, and are not parasitic)"Not to mention its there for a reason to fight bad bacteria."It has many functions inside our digestive tract, one of them to recognize and destroy harmful bacteria."Is killing it a good idea or does that open a person up to other harmful bacteria that it defends a person from?On these symptoms "burning eyes, fatigue, hyperactivity, headache." could all possible be explained more easily perhaps. One might be allergies for example. There you might be thinking yu are somehow allergic to candida? That might be a possiblity perhaps. Those are common symptoms to a whole list of conditions though and might not all be describe as toxic or even related to the same problems. IBS and for some other reasons and conditions we have seen on the bb that low sugar diets can help IBS, but for a different reason then candida."See my post in the recent thread on Vivonex and candida."I have to say without references and what I have read and that is quite a bit actually on it and people I have talked to who do the testing, something is amiss.Without the refernces its anecdotal really. Where is the research and the studies? In the last five years regardles of IBS or other conditions have learned a lot about the colon and how it works. Not everything but a lot, especially with new technology. I can say I am no expert either, perhaps some people are allergic to it somehow, but would seem to cause other symptoms oragnic in nature.If I had C personally the first test other the a colonoscopy would be a sitz marker test. That is a major test for c. What if your treating the wrong problems and your doing all this and have something else? For me that is why testing is majorally important and working with a good doctor.Lets say for arguements sake you don't have candida but one of the much more common reasons for c, like pelvic floor dyssynergia or functional constipation which are very common problems. On the amount of antibiotics you took, were you checked for C-diff that is common in such cases. Sugar could be a sugar absorbition problem or sugar feed the normal bowel bacteria and cause more gas and pressure in the gut. Reducing that even in IBS helps some people. The gut works by pressure sensitive cells. But on CConstipation can be classified into 3 broad categories: normal-transit constipation, slow-transit constipation, and disorders of defecation or rectal evacuation.8 Normal-transit constipation is the most common type. Patients report feeling constipated even though their stools pass through the colon at a normal rate and the frequency of movements is within the normal range. Patients may perceive their bowel habits as abnormal because of abdominal pain, bloating, straining, or hard stools.8 Patients with IBS have symptoms similar to those of normal-transit constipation; however, abdominal pain, in association with changes in stool frequency and consistency, must be present before IBS can be diagnosed.9Slow-transit constipation is caused by impaired phasic colonic motor activity, delayed emptying of the proximal colon, and reduced high-amplitude peristaltic contractions after meals.8 It is most common in young women, and onset usually occurs at puberty. Patients report infrequent BMs (<1 per week), although straining is not a common symptom in this form of constipation. Disorders of defecation are usually due to dysfunction of the pelvic floor or anal sphincter. Failure of the rectum to empty effectively may result from ineffective coordination of the abdominal, anorectal, and pelvic floor muscles during defecation.8 Patients with pelvic floor disorders typically describe an inability to defecate despite a sense of urgency, although they often report straining on defecation and the need for manual digitation."Have you ever had a sitz marker test?I hope this post comes out the right way, just trying to help so you know. I understand its your body.Have you seen this book?Book ReviewCandida and Candidiasisfrom Emerging Infectious DiseasesPosted 10/01/2002Mary E. BrandtRichard A. Calderone, editorAmerican Society for Microbiology Press, Washington, 2001, 472 pagesYeast of the genus Candida have exploded into prominence in recent years as opportunistic and nosocomial fungal pathogens. However, the most recent textbook on these organisms was written in 1988. Candida and Candidiasis is a worthy successor in providing comprehensive information on the biology of these organisms.A total of 28 chapters cover the general properties, virulence factors, cell biology, immunity, genomics, diseases, and laboratory aspects of Candida species, with particular emphasis on its most prominent member, Candida albicans. The strongest chapters are those covering research aspects of these organisms. Complex subjects like the chemistry of the cell wall, host recognition and adherence, the cell biology of the yeast-hyphal transformation, and extracellular hydrolases as virulence factors in C. albicans are well summarized with clear, useful graphics and current references. The book is beautifully laid out, with a series of color plates that help describe phenotype switch variants and chromosome maps.The clinical chapters appear rather superficial for an infectious diseases clinician but may be useful to a student seeking basic material. The chapter on identification and subtyping contains information available in other sources for less than the cost of this book. A discussion of current practices in antifungal susceptibility testing of Candida species would have been helpful. Chapters 2 and 4 contain repetitious material, including photographs of C. dubliniensis. A consolidated chapter on the epidemiology of Candida infections should be considered for the next edition. The chapters covering the cell biology are most useful, either as a comprehensive overview or as a reference text for researchers and students interested in the biology of these organisms.Mary E. Brandt, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Emerg Infect Dis 8(8), 2002. © 2002 Centers for Disease Control and Prevention (CDC)also medscape has a lot of info on candidafor example"Changing Microbiologic Spectrum of CandidaAlthough there are more than 100 described species of Candida, only four are commonly associated with infection: C. albicans, C. tropicalis, C. parapsilosis, and C. glabrata.10 Of these, C. albicans has been isolated from more than 60% of candidal infections; the other three major species are seen at rates varying from 5% to 20%. Mucosal colonization by C. tropicalis, a virulent organism, frequently leads to invasive infection. C. glabrata and C. parapsilosis appear to be relatively less virulent,111 and the latter typically causes infection in association with prosthetic materials (e.g., catheters) or glucose-rich intravenous solutions.10 Finally, C. kruseiand C. lusitaniae rarely cause disease, being isolated from fewer than 1% of cultures.10
The epidemiology of candidiasis has changed, with reduced rates of C. albicans in favor of other candidal species-in particular, C. glabrataand C. krusei.112 This change is important because C. krusei and several strains of C. glabrataare highly resistant to the triazoles such as fluconazole and itraconazole.10,112A study by the NNIS group evaluated 1,579 bloodstream isolates of Candida species obtained from more than 50 hospitals in the United States over a 7-year period (1992â€"1998) to detect trends in species distribution and susceptibility to fluconazole. C. albicans accounted for 52% of isolates, followed by C. glabrata(18%), C. parapsilosis (15%), C. tropicalis (11%), and C. krusei (2%). Since 1995, C. glabrata has been more prevalent than C. parapsilosis. The susceptibility of all Candida species to fluconazole has remained stable.113a"I highlighted that one sentence because it was interesting.
http://www.medscape.com/viewarticle/535493http://www.medscape.com/gastroenterologyI also posted that new thread on here on gut bacteria, you might be interested in.